|
Category:
|
7TM Receptors Peptides (Gastrointestinal)CCK Receptors
|
|
Cat.No.
|
Product Name
|
|
2304 |
Devazepide
|
| Alternative name(s): |
L-364,718 |
|
MK 329 |
|
|
Price and Availability
Click here for full price details of
Devazepide
|
|
|
|
|
Biological Activity:
Potent, orally active
CCK1 (CCK-A) receptor antagonist that displays appetite-stimulant
effects. Blocks the anorectic response to CCK-8 and increases food intake in
rats following systemic and i.c.v administration.
|
Technical Data:
|
|
|
Resources:
|
|
Certificate of Analysis / MSDS:
|
References:
Ebenezer
(2002) Effects of
intracerebroventricular administration of the CCK1 receptor antagonist
devazepide on food intake in rats. Eur.J.Pharmacol. 441 79. Reidelberger
et al (2003) Effects of peripheral CCK receptor blockade on food intake
in rats. Am.J.Physiol.Reg.Integr.Comp.Physiol. 285 R429. Ritter
(2004) Increased food intake and CCK receptor antagonists: beyond abdominal
vagal afferents. Am.J.Physiol.Reg.Integr.Comp.Physiol. 286 R991.
|
|
View related products by Pharmacological Action
or by Research Area
Keywords: Devazepide, Peptides (Gastrointestinal), Selective, Orally Active CCK1 Receptor Antagonist, L-364,718, MK 329, Tocris Bioscience
|
|
| “Our laboratory loves dealing with Tocris and consider many of the compounds you sell to be far better quality than the compounds that we have received from other companies. Once again, thank you very much..” Researcher, Albany Medical College, USA |
|
